Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Harvard Business School
Dow
Johnson and Johnson

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Eperisone


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Eperisone?

Eperisone is an investigational drug.

There have been 12 clinical trials for Eperisone. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2011.

The most common disease conditions in clinical trials are Back Pain, Spasm, and Low Back Pain. The leading clinical trial sponsors are Eisai Co., Ltd., Tanta University, and Hanmi Pharmaceutical Company Limited.

Recent Clinical Trials for Eperisone
TitleSponsorPhase
Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203Navipharm CorporationPhase 1
Cyclobenzaprine in Muscle Cramps With Liver CirrhosisTanta UniversityPhase 3
Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back PainLudwig-Maximilians - University of MunichN/A

See all Eperisone clinical trials

Clinical Trial Summary for Eperisone

Top disease conditions for Eperisone
Top clinical trial sponsors for Eperisone

See all Eperisone clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Colorcon
Harvard Business School
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.